Item
CAFFEINE ANYHYDROUS USP KOSHER SDXP (3093629 215 08M)
Beverage
Attributes
- Gluten-free
Locations
| Location name | Address |
|---|---|
| SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | 13, Huagong Road, East Chemical Zone of Zibo High & New Technology Development Zone Zibo, SD 255075 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Label Sample | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | 25kg carton.jpg | 11/24/2023 | 11/23/2024 |
| Label Guidance | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | 25kg carton.jpg | 6/13/2022 | 6/12/2024 |
| Label Claims | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | 25kg carton.jpg | 6/13/2022 | 6/12/2024 |
| Allergens | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Allergens.pdf | 2/16/2022 | 2/16/2024 |
| Animal Testing Statement | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Animal Testing Statement.pdf | 6/13/2022 | 6/12/2024 |
| BSE - TSE | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | BSE-TSE statement.pdf | 11/24/2023 | 11/23/2026 |
| HACCP | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Caffeine HACCP.pdf | 6/3/2020 | 6/3/2023 |
| CoA Sample | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | COA OF CAFFEINE 2203326.pdf | 6/13/2022 | 6/12/2024 |
| Country of Origin | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Country of Origin.pdf | 11/24/2023 | 11/23/2026 |
| Dietary Supplement Questionnaire | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Dietary Supplement Questionnaire.pdf | 11/24/2023 | 11/23/2024 |
| Heavy Metal | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Elemental Impurities - Caffeine.pdf | 6/13/2022 | 6/12/2024 |
| EtO Statement | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | EtO Statement.pdf | 6/13/2022 | 6/12/2024 |
| HACCP Process Flow Diagram | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Flow Chart of Caffeine - CCP.pdf | 6/13/2022 | 6/12/2024 |
| Food Contact Packaging Certificate of Compliance | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Food Contact Packaging Certificate of Compliance.pdf | 6/13/2022 | 6/12/2024 |
| FSVP Assessment Form | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | FSVP Assessment Form.pdf | 11/24/2023 | 11/23/2024 |
| Gluten | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Gluten free Statement.pdf | 11/24/2023 | 11/23/2024 |
| GMO | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | GMO Free Statement.pdf | 6/13/2022 | 6/12/2024 |
| GRAS/NDI/ODI Statement | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | GRAS Statement.pdf | 6/5/2020 | 6/5/2023 |
| Halal | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | halal cert. of caffeine.pdf | 10/11/2022 | 9/30/2024 |
| Ingredient Statement | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Ingredient statement.pdf | 6/24/2022 | 6/24/2023 |
| Irradiation Status Statement | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Irradiation free Statement.pdf | 6/13/2022 | 6/12/2024 |
| Item Questionnaire | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Item Questionnaire.pdf | 6/24/2022 | 6/23/2025 |
| Kosher | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | LetterOfCertification_U53R0GYA.pdf | 12/8/2023 | 12/31/2024 |
| Lot Code | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Lot Number Statement.pdf | 6/16/2021 | 6/15/2024 |
| National Bioengineered Food Disclosure Standard (Simplified) | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | National Bioengineered Food Disclosure Standard (Simplified).pdf | 11/24/2023 | 11/23/2026 |
| Natural | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Natural Statement .pdf | 6/24/2022 | 6/24/2023 |
| No Animal Ingredient Statement | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | No animal testing statement.pdf | 11/24/2023 | 11/23/2024 |
| HARPC Food Safety Plan (Item) | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | NotApplicable_HARPCFoodSafetyPlanItem.pdf | 12/19/2024 | 12/19/2027 |
| Organic | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | NotApplicable_Organic.pdf | 6/3/2020 | -- |
| Nutrition | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Nutrition.pdf | 6/3/2020 | 6/3/2023 |
| Pesticide | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Pesticide free statement.pdf | 6/13/2022 | 6/12/2024 |
| Phthalate Esters Letter | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Phthalate Esters free statement.pdf | 11/24/2023 | 11/23/2024 |
| California Prop. 65 | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Proposition 65 Statement.pdf | 6/13/2022 | 6/12/2024 |
| Residual Statement | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Residual Solvent statement.pdf | 11/24/2023 | 11/23/2024 |
| Safety Data Sheet (SDS) | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | SDS of Caffeine.pdf | 5/25/2022 | 5/24/2025 |
| Sewage Statement | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Sewage Sludge Statement.pdf | 6/13/2022 | 6/12/2024 |
| Shelf Life | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Shelf Life Statement.pdf | 6/13/2022 | 6/12/2025 |
| Suitability Requirements | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | Suitability Requirements.pdf | 7/12/2023 | 7/11/2026 |
| Product Specification Sheet | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | technical specification of caffeine - BP EP USP.pdf | 1/11/2024 | 1/10/2027 |
| WADA/NSF/NFL Statement | SHANDONG XINHUA PHARMACEUTICAL CO - MITSUBISHI | WADA statement.pdf | 6/13/2022 | 6/12/2024 |
